Cargando…
Antibacterials/convalescent-anti-SARS-CoV-2-plasma/hydroxychloroquine: Off-label use and lack of efficacy: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023700/ http://dx.doi.org/10.1007/s40278-022-13600-5 |
Ejemplares similares
-
Convalescent-anti-SARS-CoV-2-plasma: Lack of efficacy following off-label use: case report
Publicado: (2021) -
Convalescent-anti-SARS-CoV-2-plasma: Lack of efficacy following off-label use: case report
Publicado: (2022) -
Convalescent anti SARS-CoV-2 plasma/norepinephrine/tocilizumab: Lack of efficacy and off-label use: case report
Publicado: (2021) -
Convalescent-anti-SARS-CoV-2-plasma/dexamethasone/remdesivir: Off-label use and lack of efficacy: case report
Publicado: (2021) -
Convalescent-anti-SARS-CoV-2-plasma/heparin: Lack of efficacy following an off-label treatment: case report
Publicado: (2022)